ID

31215

Description

AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00961415

Link

https://clinicaltrials.gov/show/NCT00961415

Keywords

Versions (1)
  1. 7/29/18 7/29/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 29, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415

English

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adults >/=18 years of age
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
inoperable, locally advanced, metastatic or recurrent non-squamous nsclc
Description

Non-squamous non-small cell lung cancer Inoperable | Non-squamous non-small cell lung cancer Advanced Locally | Non-squamous non-small cell lung cancer metastatic | Non-squamous non-small cell lung cancer Recurrent

Data type

boolean

Alias
UMLS CUI [1,1]
C4324656
UMLS CUI [1,2]
C0205187
UMLS CUI [2,1]
C4324656
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
UMLS CUI [3,1]
C4324656
UMLS CUI [3,2]
C1522484
UMLS CUI [4,1]
C4324656
UMLS CUI [4,2]
C2945760
at least 1 measurable lesion meeting recist criteria
Description

Measurable lesion Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
ecog performance status 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, liver and renal function
Description

Hematologic function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy or treatment with another systemic anti-cancer agent
Description

Prior Chemotherapy | Antineoplastic Agents Systemic

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0003392
UMLS CUI [2,2]
C0205373
malignancies other than nsclc within 5 years prior to randomization, except for adequately treated cracinoma in situ of the cervix, basal or squameous cell skin cancer, localized prostate cancer or dcis
Description

Cancer Other | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Prostate carcinoma Localized | DCIS

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0553723
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C0600139
UMLS CUI [5,2]
C0392752
UMLS CUI [6]
C0007124
evidence of tumour invading major blood vessels
Description

Tumor Invasion Blood Vessels Major

Data type

boolean

Alias
UMLS CUI [1,1]
C1269955
UMLS CUI [1,2]
C0005847
UMLS CUI [1,3]
C0205164
current or recent use of aspirin (>325mg/day) or full-dose anticoagulants or thrombolytic agents for therapeutic purposes
Description

Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003280
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0443225
UMLS CUI [3]
C0016018
history of haemoptysis >/=grade 2
Description

Hemoptysis Grade

Data type

boolean

Alias
UMLS CUI [1,1]
C0019079
UMLS CUI [1,2]
C0441800
clinically significant cardiovascular disease
Description

Cardiovascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222
Back to the top of the page

Similar models

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00961415

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adults >/=18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-squamous non-small cell lung cancer Inoperable | Non-squamous non-small cell lung cancer Advanced Locally | Non-squamous non-small cell lung cancer metastatic | Non-squamous non-small cell lung cancer Recurrent
Item
inoperable, locally advanced, metastatic or recurrent non-squamous nsclc
boolean
C4324656 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C4324656 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C4324656 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C4324656 (UMLS CUI [4,1])
C2945760 (UMLS CUI [4,2])
Measurable lesion Quantity
Item
at least 1 measurable lesion meeting recist criteria
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
adequate hematological, liver and renal function
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | Antineoplastic Agents Systemic
Item
prior chemotherapy or treatment with another systemic anti-cancer agent
boolean
C1514457 (UMLS CUI [1])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Cancer Other | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Prostate carcinoma Localized | DCIS
Item
malignancies other than nsclc within 5 years prior to randomization, except for adequately treated cracinoma in situ of the cervix, basal or squameous cell skin cancer, localized prostate cancer or dcis
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0600139 (UMLS CUI [5,1])
C0392752 (UMLS CUI [5,2])
C0007124 (UMLS CUI [6])
Tumor Invasion Blood Vessels Major
Item
evidence of tumour invading major blood vessels
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent use of aspirin (>325mg/day) or full-dose anticoagulants or thrombolytic agents for therapeutic purposes
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
Hemoptysis Grade
Item
history of haemoptysis >/=grade 2
boolean
C0019079 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial